Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

B2B Pharmaceutical Trading App Yaoshibang Raises RMB 420 Mln Series C, 6/14/18

Guangzhou-based Sudao Information Technology, operator of mobile B2B pharmaceutical trading app Yaoshibang, has completed RMB 420 mln in Series C funding across two rounds. Shunwei Capital Partners led Series C1 funding with participation from Series B leader Green Pine Capital and ECC Capital. DCM Ventures led Series C2 with participation from SIG. To date, Yaoshibang has raised over RMB 600 mln.

Yaoshibang currently has over 150,000 active pharmacies and a monthly GMV of RMB 500 mln. The platform is expected to reach total annual transaction volume of RMB 10 bln this year.

Editor's Note: For more information on this topic, please see B2B Pharmaceutical Trading App 'Yaoshibang' Wins RMB 110 Mln Series B, MD 2/07/17 issue.

Keywords: mobile healthcare ECC Capital VC m-commerce B2B funding wireless SIG DCM Ventures Green Pine Series B Series C Shunwei Sudao Yaoshibang


Please note, all fields are required.
None of your personal information will be shared with third parties.



The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports